7-Bromoisoquinolin-3-amine, 95.0%, 250mg

methyl bicyclo[1.1.1]pentane-1-carboxylate, 97, 5g

Hexano (isómeros), mínimo 95 % (isómeros), para síntesis, 2,5 L, envase de vidrio

Balicatib, 98%, 10mg

H-D-Cys-Ome.hcl, 95%, 25g

Benzenesulfonamide>98.0%(HPLC)(N)25g

8-Bromo-6-chloro-2-cyclopropylimidazo[1,2-b]pyridazine, 97%, 100mg

(E)-Oct-2-enoic acid, 98%, 10g

Methyl 4-bromo-3-chloro-2-methylbenzoate, 97%, 500mg

2,6-Dibromo-4-nitroaniline>98.0%(GC)500g

N-Boc-O-2-propyn-1-yl-L-tyrosine, 95%, 1g

Fmoc-EDA.HCl, 99.0%, 5g

Methyl 5-bromo-2-cyanobenzoate, 95.0%, 250mg